	Do apelin and ghrelin play a role in multiple sclerosis? The analysis of patients treated with immunomodulatory therapies. Front Immunol Adamczyk B, Morawiec N, Rakoca M, Sowa A, Sawa K, Adamczyk-Sowa M. PMID: 42131351 [PubMed - indexed for MEDLINE]
	Oxidized mannan-MOG35-55 conjugate as a platform for antigen-specific immune modulation in multiple sclerosis. Front Immunol Mouzaki A, de Lastic AL, Apostolopoulos V, Matsoukas I. PMID: 42131329 [PubMed - indexed for MEDLINE]
	Serum neurofilament light chain and multiple sclerosis prognosis: a systematic review and meta-analysis. Front Immunol Chen Y, Cai M, Lv X. PMID: 42131327 [PubMed - indexed for MEDLINE]
	PRIMUS: a precision medicine platform reusing clinical trials and registry data to support treatment selection in multiple sclerosis. JAMIA Open Demuth S, Faddeenkov I, Paris J, Rousseau O, Baciotti B, Payet M, Casey R, Vukusic S, Doyle S, Jarre G, Vince N, Limou S, De Sèze J, Kerbrat A, Laplaud D, Edan G, Gourraud PA, PRIMUS Consortium. PMID: 42131074 [PubMed]
	Multiple sclerosis diagnosis in south Asia: fundamentals first. Lancet Reg Health Southeast Asia The Lancet Regional Health-Southeast Asia. PMID: 42130678 [PubMed]
	Which medication improves fatigue in patients with multiple sclerosis (MS)?: a systematic review and network meta-analysis. Neurodegener Dis Manag Rastkar M, Ghandchi S, Ghajarzadeh M, Ghajarzadeh M. PMID: 42130400 [PubMed - as supplied by publisher]
	Flip angle in susceptibility-weighted imaging for the diagnosis of multiple sclerosis - Authors' reply. Lancet Neurol Sati P, Barkhof F, Reich DS, Ontaneda D, Rovira À. PMID: 42127925 [PubMed - in process]
	Flip angle in susceptibility-weighted imaging for the diagnosis of multiple sclerosis. Lancet Neurol Sonoda Y, Hagiwara A, Tomizawa Y, Hatano T, Kamagata K. PMID: 42127924 [PubMed - in process]
	Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis. Lancet Neurol Zettl UK, Rommer PS, Wattjes MP, Tumani H, Hecker M. PMID: 42127923 [PubMed - in process]
	Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis - Authors' reply. Lancet Neurol Montalban X, Oh J, Coetzee T, Thompson AJ. PMID: 42127922 [PubMed - in process]
	Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis. Lancet Neurol Krieger S. PMID: 42127921 [PubMed - in process]
	Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis. Lancet Neurol Okuda DT, Kantarci OH, Siva A, Pelletier D, Lebrun-Frénay C, RISConsortium. PMID: 42127920 [PubMed - in process]
	Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis. Lancet Neurol Toosy A, Oertel FC, Petzold A, Albrecht P, IMSVISUAL. PMID: 42127919 [PubMed - in process]
	Serum Glial Fibrillary Acidic Protein and Retinal Neuronal Loss as Additive Prognostic Markers of Disability in Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm Sellathurai S, Schoenholzer K, Burguet Villena F, Cerdá-Fuertes N, Hofer L, Schaedelin SA, Kana V, Mahenthiran P, D'Souza M, Maleska Maceski A, Derfuss TJ, Oechtering J, Gugleta K, Kappos L, Petzold A, Granziera C, Benkert P, Kuhle J, Papadopoulou A. PMID: 42127333 [PubMed - indexed for MEDLINE]
	Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis. Drugs Lambe J, Fox RJ. PMID: 42126690 [PubMed - as supplied by publisher]
	Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohort. J Neurol Filippi M, D'Amico E, Brescia Morra V, Zanetta C, Zanghì A, Di Filippo PS, Longobardi E, Colombo E, Mirabella M, Conte A, Tomassini V, Masini C, Perosino V, Tortorella P, Rocca MA, MUPSO Study Group. PMID: 42126632 [PubMed - indexed for MEDLINE]
	Misclassification bias in chronic disease case ascertainment algorithms: a reclassification approach. Health Promot Chronic Dis Prev Can Hamm NC, Marrie RA, Jiang D, Irani P, Lix LM. PMID: 42126353 [PubMed - indexed for MEDLINE]
	Integrating Genetics and Environment to Find Causal Mechanisms for Multiple Sclerosis. Eur J Immunol Leon AM, Lincoln MR. PMID: 42125982 [PubMed - indexed for MEDLINE]
	A glial oxidative signature predicts disability in primary progressive multiple sclerosis and is associated with long-term cognitive decline. Front Immunol Miguela A, Huertas-Pons JM, Coll-Martinez C, Gifreu-Fraixinó A, Salavedra-Pont J, Comabella M, Villar LM, Gich J, Álvarez-Bravo G, Ramió-Torrentà L, Quiroga-Varela A. PMID: 42125662 [PubMed - indexed for MEDLINE]
	Dysphagia Risk and Its Association with Nutritional Status in Multiple Sclerosis: A Preliminary Study. Nutrients Franchina Vergel NV, Molina-López J, Planells E. PMID: 42123917 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 43971

Page 1 of 2199



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy